Navigation Links
CIAs in Medical News

When CIAs Poisoned Capsule for Castro Stuck to the Freezer!

That the notorious US Central Intelligence Agency mounted innumerable attempts to kill its bete noire, Cubas Fidel Castro, is well known . Forget the politics of it all, the CIA has indeed been resourceful, even if they came to grief every time. Castro has already turned 80. Still the recen...

A Drug That Receives Regulatory Approval for Cognitive Impairment Associated With Schizophrenia Would Earn a Higher Patient Share in the United States Than in Europe

... CIAS. To date, no drugs are formally approved for cias and off-label treatment is sporadic. However, clin...and Merck could demonstrate advantages in treating cias when compared with donepezil (Eisai/Pfizer's Arice...en benefits in other indications in the hopes that cias patients will experience similar benefits," said D...

Memory Pharmaceuticals Closes Second Tranche of Equity Financing with The Stanley Medical Research Institute

...tional milestone related to the Phase 2a trial of MEM 3454 in CIAS. "We are extremely pleased with the progress of our Phase 2a trial of MEM 3454 in cias and that we have been able to translate our achievements into an opportunity to raise additional capital at favorable terms," stated Vaughn M. Kailian...

Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease

...ated with schizophrenia. The expanded agreement provides that Roche would have to make an additional milestone payment upon completion of the Phase 2a cias trial in order to maintain its license to MEM 3454. Under this agreement, Memory Pharmaceuticals and Roche actively collaborate on the discovery and ...
CIAs in Medical Technology

Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia

...87/MEM 3454 or placebo once daily for a period of eight weeks. The primary objective of the trial is to assess the effectiveness of R3487/MEM 3454 in cias using the MATRICS Consensus Cognitive Battery (MCCB). Secondary objectives include assessing the effectiveness of the drug to improve other symptoms o...

Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program

...ment associated with the completion of the Phase 2 cias trial as follows: $3.5 million in connection with ... million upon the completion of enrollment for the cias trial. The payment of the remaining $8.5 million w...the availability of top-line data from the Phase 2 cias trial, which is now expected in the second quarter...

Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia

.... To maintain its license to MEM 3454, Roche would have to make an additional milestone payment to the Company upon completion of the ongoing Phase 2a cias trial, which is expected to be completed in the fourth quarter of 2008. Evoked Potentials in Schizophrenia Electrophysiology measures have long be...

TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia

...plans to initiate a Phase II dose-ranging trial in cias during the first half of 2008. A secondary object...ned timing of the initiating of clinical trials in cias and xerostomia. Such statements are subject to num...ee that NGX267 will successfully treat symptoms of cias or xerostomia, the dose range may not be effective...
CIAs in Biological Technology

Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results

...he. During the quarter, we also achieved a milestone related to the Phase 2 cias trial under our equity financing agreement with SMRI, triggering an additio...me due 30 days following the availability of top-line data from the Phase 2 cias trial. In addition, Roche has agreed to fund all internal and external cost...

Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia

...rial is to assess the effectiveness of MEM 3454 in cias using the MATRICS Consensus Cognitive Battery (MCC... milestone payment upon completion of the Phase 2a cias trial to maintain its license to MEM 3454. The add...cted to cover the expenses related to the Phase 2a cias trial of MEM 3454. MEM 3454 is a partial agonist...
Other Tags
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best ... sponsor of the “Music With A Mission” benefit concert in Mendon, IL. Held in ... to raise money to support music education programs in the underfunded local school districts ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, Inc., the maker ... data center assets and audio-video devices, recently released Visio Stencils for the following ... ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems ...
(Date:8/28/2015)... ... 28, 2015 , ... CARF International announced that West Ridge ... treatment and intensive family based services. , By pursuing and achieving accreditation, West ... of excellence. As a nonprofit charity for more than 50 years, West Ridge ...
(Date:8/28/2015)... ... August 28, 2015 , ... Northridge dentists Dr. ... whitening. For just $199, patients can currently receive a one hour treatment of this ... procedures, but it includes a number of unique features that can turn teeth up ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... which is dedicated to distributing health information technology innovation to transform quality and ... Results of the survey will be de-identified and aggregated before being publicly shared ...
Breaking Medicine News(10 mins):Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2
(Date:8/26/2015)... 26, 2015 The report "Multi-Factor Authentication ... Factor), Application (Travel & Immigration, Government, Banking, Defense, Commercial ... to 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is ... at a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ...
(Date:8/24/2015)... TOWN, South Africa , August 24, 2015 ... Germany ,s largest biometrics manufacturer DERMALOG and ... with the "2015 African Biometrics Company of the Year ... in Nigeria .   -Cross ... and http://www.presseportal.de/nr/8896 - On Thursday evening, ...
(Date:8/20/2015)... PLEASANTON, Calif. , Aug. 20, 2015 /PRNewswire/ ... focused on consumers that are active and healthy. ... used in the hospital environment to help improve ... released a video from the Wearable Technologies ... MD discussed new applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
Other Contents